This study provides an estimate of antimicrobial resistance in intestinal indicator bacteria from humans (n = 97) and food animals (n = 388) in Tanzania. More than 70% of all fecal samples contained tetracycline (TE), sulfamethoxazole (STX), and ampicillin (AMP)-resistant coliforms, while cefotaxime (CTX)-resistant coliforms were observed in 40% of all samples. The average Log10 colony forming units/g of CTX-resistant coliforms in samples from humans were 2.20. Of 390 Escherichia coli tested, 66.4% were resistant to TE, 54.9% to STX, 54.9% to streptomycin, and 36.4% to CTX. Isolates were commonly (65.1%) multiresistant. All CTX-resistant isolates contained blaCTX-M gene type. AMP- and vancomycin-resistant enterococci were rare, and the average concentrations in positive samples were low (log10 0.9 and 0.4, respectively). A low-to-moderate resistance (2.1–15%) was detected in 240 enterococci isolates to the drugs tested, except for rifampicin resistance (75.2% of isolates). The average number of sulII gene copies varied between Log10 5.37 and 5.68 with no significant difference between sample source, while cattle had significantly higher number of tetW genes than humans. These findings, based on randomly obtained samples, will be instrumental in designing antimicrobial resistance (AMR) intervention strategies for Tanzania.
ByarugabaD.K.2004. A view on antimicrobial resistance in developing countries and responsible risk factors. Int. J. Antimicrob. Agents, 24:105–110.
3.
CarlosF.2010. Global perspectives of antibiotic resistance. In SosaA.de.J., ByarugabaD.K., Ama'bile-CuevasC.F., HsuehP.-R., KariukiS., and OkekeI.N. (ed.), Antimicrobial Resistance in Developing Countries. US Springer Science and Business Media, New York, pp. 3–14.
4.
OkekeI.N., LamikanraA., and EdelmanR.. 1999. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg. Infect. Dis., 5:18–27.
5.
JordiV., MarthaV., ClimentC., HonoratoU., HassanM., DavidS., and JoaquimG.. 1999. Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. J. Antimicrob. Agents Chemother., 43:3022–3024.
6.
BagerF.2000. Danish integrated antimicrobial resistance monitoring program. monitoring antimicrobial resistance in Denmark. Int. J. Antimicrob. Agents, 14:271–274.
7.
EFSA (European Food Safety Authority). 2009. Scientific opinion of the panel on biological hazards on a request from the European Commission on Assessment of the Public Health significance of meticillin resistant Staphylococcus aureus (MRSA) in animals and foods. EFSA J., 993:1–73.
8.
EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control). 2013. The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2011. EFSA J. 11:3196 (359 pp.).
9.
EFSA (European Food Safety Authority). 2011. Panel on biological hazards (BIOHAZ); Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA J. 9:2322 (95 pp.).
10.
PallecchiL.C., LucchettiA., BartoloniF., BartalesiA., MantellaH., GamboaA., CarattoliA., ParadisiF., and RossoliniG.M.. 2007. Population structure and resistance genes in antibiotic-resistant bacteria from a remote community with minimal antibiotic exposure. Antimicrob. Agents Chemother., 51:1179–1184.
11.
MoyoS.J., AboudS., KasubiM., and MaS.Y.. 2010. Bacterial isolates and drug susceptibility patterns of urinary tract infection among pregnant women at Muhimbili National Hospital in Tanzania. Tanzan. J. Health Res., 12:236–240.
12.
MshanaS.E., ImirzaliogluC., HainT., DomannE., LyamuyaE.F., and ChakrabortyT.. 2011. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin. Microbiol. Infect., 17:1279–1282.
13.
KajegukaD.C., NambungaP.P., KabissiF., KamugishaB., KassamN., NyombiB., MtaroC., MaroV., and ChilongolaJ.O.. 2015. Antimicrobial resistance patter, ns of phenotype extended spectrum beta-lactamase producing bacterial isolates in a referral hospital in northern Tanzania. Tanzan. J. Health Res., 17:3.
14.
KatakwebaA.A.S., MtamboM.M.A., OlsenJ.E., and MuhairwaA.P.. 2012. Awareness of human health risks associated with the use of antimicrobials among livestock keepers and factors that contribute to selection of antibiotic resistance bacteria within livestock in Tanzania. Livestock Res. Rural Dev., 24:e170.
15.
MshanaS.E., FalgenhauerL., MiramboM.M., MushiM.F., MoremiN., JuliusR., and ChakrabortyT.. 2016. Predictors of bla CTX-M-15 in varieties of Escherichia coli genotypes from humans in community settings in Mwanza, Tanzania. BMC Infect. Dis., 16:187.
16.
TellevikM.G., BlombergB., Ø. Kommedal, MaselleS.Y., LangelandN., and MoyoS.J.. 2016. High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae among children in Dar es Salaam, Tanzania. PLoS One, 11:e0168024.
17.
DestaK., WoldeamanuelY., AzazhA., MohammodH., DesalegnD., ShimelisD., GulilatD., LamissoB., MakonnenE., WorkuA., and MannerqvistK.. 2016. High gastrointestinal colonization rate with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients: emergence of carbapenemase-producing K. pneumoniae in Ethiopia. PLoS One, 11:e0161685.
18.
IsendahlJ., Turlej-RogackaA., ManjubaC., RodriguesA., GiskeC.G., and NauclérP.. 2012. Fecal carriage of ESBL-producing E. coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based cross-sectional study. PLoS One, 7:e51981.
19.
FarraA., FrankT., TondeurL., BataP., GodyJ.C., OnambeleM., RafaïC., VrayM., and BreurecS.. High rate of faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy children in Bangui, Central African Republic. Clin. Microbiol. Infect. 22:891.e1–894.e4.
20.
SchaumburgF., AlabiA., KokouC., GrobuschM.P., KöckR., KabaH., BeckerK., AdegnikaA.A., KremsnerP.G., PetersG., and MellmannA.. 2013. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon. J. Antimicrob. Chemother., 68:2140–2143.
21.
KatakwebaA.A.S., MøllerK.S., MuumbaJ., MuhairwaA.P., DamborgP., RosenkrantzJ.T., and OlsenJ.E.. 2015. Antimicrobial resistance in faecal samples from buffalo, wildebeest and zebra grazing together with and without cattle in Tanzania. J. Appl. Microbiol., 118:966–975.
22.
KronvallG., KarlssonI., WalderM., SörbergM., and NilssonL.E.. 2006. Epidemiological MIC cut-off values for tigecycline calculated from etest MIC values using normalized resistance interpretations. J. Antimicrob. Chemother., 657:498–505.
23.
Dutka-MalenS., EversS., and CourvalinP.. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol., 33:24–27.
24.
Clinical and Laboratory Standards Institute (CLSI). 2013. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, Fourth Edition: Approved Standard. M31-A4. CLSI, Wayne, PA.
25.
MagiorakosA.P., SrinivasanA., CareyR.B., CarmeliY., FalagasM.E., GiskeC.G., HarbarthS., HindlerJ.F., KahlmeterG., Olsson LiljequistB., and PatersonD.L.. 2012. Multidrug resistant, extensively drug resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect., 18:268–281.
26.
LewisJ.S.I.I., HerreraM., WickesB., PattersonJ.E., and JorgensenJ.H.. 2007. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs), as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother., 51:4015–4021.
27.
HasmanH., MeviusD., VeldmanK., OlesenI., and AarestrupF.M.. 2005. Beta-lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J. Antimicrob. Chemother., 56:115–121.
28.
ShahiS.K., SinghV.K., and KumarA.. 2013. Detection of Escherichia coli and associated b-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 b-lactamases with clindamycin and piperacillin-tazobactam. PLoS One, 8:e68234.
29.
DanzerK., and CurrieL.A.. 1998. Guidelines for calibration in analytical chemistry—part 1. Fundamentals and single component calibration (IUPAC recommendations). Pure Appl. Chem., 70:993–1014.
30.
SchmidtG.V., MellerupA., ChristiansenL.E., StåhlM., OlsenJ.E., and AngenØ.. 2015. Sampling and pooling methods for capturing herd level antibiotic resistance in swine feces using qPCR and CFU approaches. PLoS One, 10:e0131672.
31.
PrescottJ.F., BaggotJ.D., and WalkerR.D.. 2000. Antimicrobial Therapy in Veterinary Medicine. 3rd ed. Iowa State Press a Blackwell Publishing Company, Ames, IA, pp. 1–47.
32.
RolainmJ.M., MalletM.N., FournierP.E., and RaoultD.. 2004. Real-time PCR for universal antibiotic susceptibility testing. J. Antimicrob. Chemother., 54:538–541.
33.
PeiR., KimS.C., CarlsonK.H., and PrudenA.. 2006. Effect of river landscape on the sediment concentrations of antibiotics and corresponding antibiotic resistance genes (ARG). Water Res., 40:2427–2435.
34.
NdeddyA.R.J., and BabalolaO.O.. 2011. Bacterial community associated with bovine tripe sold in Mafikeng municipality, South Africa. Afr. J. Microbiol. Res., 5:1532–1538.
35.
AdeyanjuG.T., and IsholaO.. 2014. Salmonella and Escherichia coli contamination of poultry meat from a processing plant and retail markets in Ibadan, Oyo State, Nigeria. Springerplus, 3:139.
36.
HershbergerE., OpreaS.F., DonabedianS.M., PerriM., BozigarP., BartlettP., and ZervosM.J.. 2004. Epidemiology of antimicrobial resistance in enterococci of animal origin. J. Antimicrob. Chemother., 55:127–130.
37.
RobelloR.F., SouzaC.R.V., DuarteR.S., LopesR.M.M., TeixeriaL.M., and CastoA.C.D.. 2005. Characterization of S. aureus isolates. Recovered from bovine mastitis in Rio de Janeiro Brazil. J. Dairy Sci., 88:3211–3219.
38.
KarimuriboE.D., FitzpatrickJ.L., BellC.E., SwaiE.S., KambarageD.M., OgdenN.H., BryantM.J., and FrenchN.P.. 2006. Clinical and subclinical mastitis in smallholder dairy farms in Tanzania: risk, intervention and knowledge transfer. Prev. Vet. Med., 74:84–98.
39.
KalterH.D., GilmanR.H.L., MoultonH., CullottaA.R., CabreraL., and VelapatinoB.. 2010. Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study. Am. J. Trop. Med. Hyg., 82:879–888.
40.
RwegoI.B., ThomasR.G., GilbertI.B., and TonyL.G.. 2008. High rates of Escherichia coli transmission between livestock and humans in rural Uganda. J. Clin. Microbiol., 46:3187–3191.
41.
BoamahV.E., AgyareC., OdoiH., and DalsgaardA.. 2016. Antibiotic practices and factors influencing the use of antibiotics in selected poultry farms in Ghana. J. Antimicrob. Agents, 2:120.
42.
KikuviG.M., Ole-MapenayI.M., MitemaE.S., and OmbuiJ.N.. 2006. Antimicrobial resistance in Escherichia coli isolates from faeces and carcass samples of slaughter cattle, swine and chickens in Kenya. Israel J. Vet. Med., 61:82–88.
43.
KivariaF.M., NoordhuizenJ.P.T.M., and KapagaA.M.. 2006. Evaluation of the hygienic quality and associated public health hazards of raw milk marketed by smallholder dairy producers in the Dar es Salaam region, Tanzania. Trop. Anim. Health Prod., 38:185–194.
44.
ByarugabaD.K., KisameR., and OletS.. 2011. Multi-drug resistance in commensal bacteria of food of animal origin in Uganda. Afr. J. Microbiol. Res., 5:1539–1548.
45.
RuzauskasM., VirgailisM., ŠiugždinienėR., SužiedėlienėE., ŠeputienėV., DaugelavičiusR., ZieniusD., ŠengautJ., and PavilonisI.. 2009. Antimicrobial resistance of Enterococcus spp. isolated from livestock in Lithuania. Vet. Arhiv., 79:439–449.
MarshallB.M., and LevyS.B.. 2011. Food animals and antimicrobials: impacts on human health. Clin. Rev. Microbiol., 24:718–733.
48.
KlareI., BadstubnerD., KonstabelC., BohmeG., ClausH., and WitteW.. 1999. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from faecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb. Drug Resist., 5:45–52.
49.
NilssonO.2012. Vancomycin resistant enterococci in farm animals—occurrence and importance. Infect. Ecol. Epidemiol., 2:1.
50.
KühnI., IversenA., FinnM., GrekoC., BurmanL.G., BlanchA.R., VilanovaX., ManeroA., TaylorH., CaplinJ., DomínguezL., HerreroI.A., MorenoM.A., and MöllbyR.. 2005. Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Appl. Environ. Microbiol., 71:5383–5390.
51.
ThamJ., MelanderE., WalderM., and OdenholtI.. 2012. Prevalence of extended-spectrum beta-lactamase-producing bacteria in food. Infect. Drug Resist., 5:143–147.
52.
KluytmansJ.A., OverdevestI.T., WillemsenI., Kluytmans-van den BerghM.F., van der ZwaluwK., HeckM., RijnsburgerM., Vandenbroucke-GraulsC.M., SavelkoulP.H., JohnstonB.D., GordonD., and JohnsonJ.R.. 2013. Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin. Infect. Dis., 6:478–487.
53.
KariukiS.2010. Antimicrobial resistance in enteric pathogens in developing countries. In SosaA.de.J., ByarugabaD.K., Ama'bile-CuevasC.F., HsuehP.-R., KariukiS., and OkekeI.N. (ed.), Antimicrobial Resistance in Developing Countries. US Springer Science and Business Media, New York, pp. 177–197.
54.
Colomer-LluchM., JofreJ., and MuniesaM.. 2011. Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples. PLoS One, 6:e17549.
55.
KatereggaJ.N., KantumeR., AtuhaireC., LubowaM.N., and NdukuiJ.G.. 2015. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda. BMC Pharmacol. Toxicol., 16:14.
56.
StorbergV.2014. ESBL-producing Enterobacteriaceae in Africa: a non-systematic literature review of research published 2008–2012. Infect. Ecol. Epidemiol. 4 [Epub ahead of print]; DOI: 10.3402/iee.v4.20342.
57.
CDC-Center for Disease Dynamics, Economics and Policy. 2015. State of the World's Antibiotics. CDDEP, Washington, D.C., 2015.
58.
ZowawiH.M., BalkhyH.H., WalshT.R., and PatersonD.L.. 2013. β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin. Microbiol. Rev., 26:361–380.
59.
SondaT., KumburuH., van ZwetselaarM., AlifrangisM., LundO., KibikiG., and AarestrupF.M.. 2016. Meta-analysis of proportion estimates of extended-spectrum-beta-lactamase producing Enterobacteriaceae in East Africa hospitals. Antimicrob. Resist. Infect. Control, 5:18.
60.
BeanD.C., LivermoreD.M., and HallL.M.C.. 2009. Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence. Antimicrob. Agents Chemother., 53:1088–1093.
61.
WhittleG., WhiteheadT.R., HamburgerN., ShoemakerN.B., CottaM.A., and SalyersA.A.. 2003. Identification of a new ribosomal protection type of tetracycline resistance gene, tet(36), from swine manure pits. Appl. Environ. Microbiol., 69:4151–4158.
62.
ScottK.P., MelvilleC.M., BarbosaT.M., and FlintH.J.. 2000. Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrob. Agents Chemother., 44:775–777.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
